Study: Statins, Ezetimibe Can Usually Tame High Cholesterol

Research suggests that relatively few people need the new injectable PCSK9 inhibitors to get their LDL cholesterol levels down to a healthy range.

Published: September 28, 2017

In the past couple of years, a new and powerful agent has become available. PCSK9 inhibitors are injectable drugs that can significantly reduce LDL (bad) cholesterol levels, especially when used in conjunction with a statin. However, PCSK9 inhibitors are expensive-more than $10,000 per year-making them an unrealistic option for many people with high cholesterol.